Patterns of Prostate-Specific Antigen Test Use in the U.S., 2005–2015

Details

• Alternative Title:
  Am J Prev Med
• Personal Author:
  Berkowitz, Zahava ; Li, Jun ; Richards, Thomas B. ; Marcus, Pamela M.
• Description:
  Introduction:
  
  Recommendations for prostate-specific antigen-based screening for prostate cancer are placing increasing emphasis on men aged 55–69 years. The goal of the current study is to describe patterns of population-based prostate-specific antigen testing with details about that age group.
  
  Methods:
  
  National Health Interview Surveys from 2005 to 2015 were analyzed in 2017 to estimate routine prostate-specific antigen testing in the past year from self-reported data by age group (40–54, 55–69, ≥70 years), and also by risk group, defined as African American men or men with a family history of prostate cancer versus other men. Differences between successive survey years by age and risk groups were assessed by predicted margins and rate ratios with 99% CIs, using logistic regressions.
  
  Results:
  
  Prostate-specific antigen testing among men aged 55–69 years decreased from a high of 43.1% (95% CI=40.3, 46.1) in 2008 to a low of 32.8% (95% CI=30.8, 34.7) in 2013, with no significant change in 2015 at 33.8% (95% CI=31.3, 36.4). Men aged ≥70 years had consistently high prevalence in all survey years, ranging from 51.1% in 2008 to 36.4% in 2015. African American men, men with a family history of prostate cancer, and other men showed a 5% absolute decrease over time, but this reduction was significant only in other men.
  
  Conclusions:
  
  Despite decreases, the absolute change in prostate-specific antigen testing for men aged 55–69 years was small (9.3%) over the study period. Men aged ≥70 years, for whom the benefits are unlikely to exceed the harms, continue to have consistently high testing prevalence.
  
  
• Subjects:
  Adult Aged Age Factors Black Or African American Family Health Health Surveys Humans Logistic Models Male Mass Screening Middle Aged Prostate-Specific Antigen Prostatic Neoplasms Risk Factors Time Factors

  More +
• Source:
  Am J Prev Med. 53(6):909-913.
• Pubmed ID:
  29051016
• Pubmed Central ID:
  PMC6077842
• Document Type:
  Journal Article
• Funding:
  CC999999/Intramural CDC HHS/United States
• Place as Subject:
  United States
• Volume:
  53
• Issue:
  6
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:ed4ae2bb50cade398a40424d3e0947dbc43c257e7724d5874a6dacc4e39bab5e
• Download URL:
  https://stacks.cdc.gov/view/cdc/57899/cdc_57899_DS1.pdf
• File Type:
  [PDF - 246.40 KB ]